Literature DB >> 24378396

Multivariate SAR and QSAR of cucurbitacin derivatives as cytotoxic compounds in a human lung adenocarcinoma cell line.

Karen L Lang1, Izabella T Silva2, Vanessa R Machado2, Lara A Zimmermann2, Miguel S B Caro3, Cláudia M O Simões2, Eloir P Schenkel2, Fernando J Durán4, Lílian S C Bernardes2, Eduardo B de Melo5.   

Abstract

This article describes structure-activity relationship (SAR/QSAR) studies on the cytotoxic activity in a human lung adenocarcinoma cell line (A549) of 43 cucurbitacin derivatives. Modeling was performed using the methods partial least squares with discriminant analysis (PLS-DA) and PLS. For both studies, the variables were selected using the ordered predictor selection (OPS) algorithm. The SAR study demonstrated that the presence or absence of cytotoxic activity of the cucurbitacins could be described using information derived from their chemical structures. The QSAR study displayed suitable internal and external predictivity, and the selected descriptors indicated that the observed activity might be related to electrophilic attack on cellular structures or genetic material. This study provides improves the understanding of the cytotoxic activity of cucurbitacins and could be used to propose new cytotoxic agents.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cucurbitacins; Lung cancer; OPS; PLS; PLS-DA; QSAR

Mesh:

Substances:

Year:  2013        PMID: 24378396     DOI: 10.1016/j.jmgm.2013.12.004

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  5 in total

1.  Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549.

Authors:  Izabella Thaís Silva; Fabiana Cristina Geller; Lara Persich; Sabine Eva Dudek; Karen Luise Lang; Miguel Soriano Balparda Caro; Fernando Javier Durán; Eloir Paulo Schenkel; Stephan Ludwig; Cláudia Maria Oliveira Simões
Journal:  Invest New Drugs       Date:  2016-01-16       Impact factor: 3.850

2.  In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B.

Authors:  Izabella T Silva; Annelise Carvalho; Karen L Lang; Sabine E Dudek; Dörthe Masemann; Fernando J Durán; Miguel S B Caro; Ulf R Rapp; Viktor Wixler; Eloir P Schenkel; Cláudia M O Simões; Stephan Ludwig
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

3.  A computational method for the identification of candidate drugs for non-small cell lung cancer.

Authors:  Lei Chen; Jing Lu; Tao Huang; Yu-Dong Cai
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

4.  Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.

Authors:  Fabiana Gomes Nascimento Soares; Gabriela Göethel; Luciano Porto Kagami; Gustavo Machado das Neves; Elisa Sauer; Estefania Birriel; Javier Varela; Itamar Luís Gonçalves; Gilsane Von Poser; Mercedes González; Daniel Fábio Kawano; Fávero Reisdorfer Paula; Eduardo Borges de Melo; Solange Cristina Garcia; Hugo Cerecetto; Vera Lucia Eifler-Lima
Journal:  BMC Pharmacol Toxicol       Date:  2019-12-19       Impact factor: 2.483

Review 5.  Citrullus colocynthis (L.) Schrad (Bitter Apple Fruit): Promising Traditional Uses, Pharmacological Effects, Aspects, and Potential Applications.

Authors:  Qin-Yuan Li; Mahzaib Munawar; Muhammad Saeed; Ji-Qiang Shen; Muhammad Sajjad Khan; Sobia Noreen; Mahmoud Alagawany; Muhammad Naveed; Asadullah Madni; Chang-Xing Li
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.